TERT genetic variability and telomere length as factors affecting survival and risk in acute myeloid leukaemia

Abstract Acute myeloid leukaemia (AML) is a neoplasm of immature myeloid cells characterized by various cytogenetic alterations. The present study showed that in addition to the FLT3-ITD and NPM1 mutation status, telomere length (TL) and telomerase reverse transcriptase (TERT) gene polymorphisms may...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Marta Dratwa, Barbara Wysoczańska, Aleksandra Butrym, Piotr Łacina, Grzegorz Mazur, Katarzyna Bogunia-Kubik
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
R
Q
Acceso en línea:https://doaj.org/article/11385e314e404688906129966ec49594
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:11385e314e404688906129966ec49594
record_format dspace
spelling oai:doaj.org-article:11385e314e404688906129966ec495942021-12-05T12:11:42ZTERT genetic variability and telomere length as factors affecting survival and risk in acute myeloid leukaemia10.1038/s41598-021-02767-12045-2322https://doaj.org/article/11385e314e404688906129966ec495942021-12-01T00:00:00Zhttps://doi.org/10.1038/s41598-021-02767-1https://doaj.org/toc/2045-2322Abstract Acute myeloid leukaemia (AML) is a neoplasm of immature myeloid cells characterized by various cytogenetic alterations. The present study showed that in addition to the FLT3-ITD and NPM1 mutation status, telomere length (TL) and telomerase reverse transcriptase (TERT) gene polymorphisms may affect risk and overall survival (OS) in AML. TL was longer in healthy controls than in AML patients and positively correlated with age in the patients, but not in healthy subjects. TL was found to be independently affected by the presence of the FLT3-ITD mutation. As for the TERT gene polymorphism, AML patients with the TERT rs2853669 CC genotype were characterized by significantly shorter OS than patients carrying the T allele. Another observation in our study is the difference in TL and OS in patients belonging to various risk stratification groups related to the FLT3-ITD and NPM1 mutation status. Patients with adverse risk classification (mutation in FLT3-ITD and lack of mutation in NPM1) presented with the shortest telomeres and significantly worse OS. In conclusion, OS of AML patients appears to be affected by TERT gene variability and TL in addition to other well-established factors such as age, WBC count, or FLT3-ITD and NPM1 mutation status.Marta DratwaBarbara WysoczańskaAleksandra ButrymPiotr ŁacinaGrzegorz MazurKatarzyna Bogunia-KubikNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 11, Iss 1, Pp 1-9 (2021)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Marta Dratwa
Barbara Wysoczańska
Aleksandra Butrym
Piotr Łacina
Grzegorz Mazur
Katarzyna Bogunia-Kubik
TERT genetic variability and telomere length as factors affecting survival and risk in acute myeloid leukaemia
description Abstract Acute myeloid leukaemia (AML) is a neoplasm of immature myeloid cells characterized by various cytogenetic alterations. The present study showed that in addition to the FLT3-ITD and NPM1 mutation status, telomere length (TL) and telomerase reverse transcriptase (TERT) gene polymorphisms may affect risk and overall survival (OS) in AML. TL was longer in healthy controls than in AML patients and positively correlated with age in the patients, but not in healthy subjects. TL was found to be independently affected by the presence of the FLT3-ITD mutation. As for the TERT gene polymorphism, AML patients with the TERT rs2853669 CC genotype were characterized by significantly shorter OS than patients carrying the T allele. Another observation in our study is the difference in TL and OS in patients belonging to various risk stratification groups related to the FLT3-ITD and NPM1 mutation status. Patients with adverse risk classification (mutation in FLT3-ITD and lack of mutation in NPM1) presented with the shortest telomeres and significantly worse OS. In conclusion, OS of AML patients appears to be affected by TERT gene variability and TL in addition to other well-established factors such as age, WBC count, or FLT3-ITD and NPM1 mutation status.
format article
author Marta Dratwa
Barbara Wysoczańska
Aleksandra Butrym
Piotr Łacina
Grzegorz Mazur
Katarzyna Bogunia-Kubik
author_facet Marta Dratwa
Barbara Wysoczańska
Aleksandra Butrym
Piotr Łacina
Grzegorz Mazur
Katarzyna Bogunia-Kubik
author_sort Marta Dratwa
title TERT genetic variability and telomere length as factors affecting survival and risk in acute myeloid leukaemia
title_short TERT genetic variability and telomere length as factors affecting survival and risk in acute myeloid leukaemia
title_full TERT genetic variability and telomere length as factors affecting survival and risk in acute myeloid leukaemia
title_fullStr TERT genetic variability and telomere length as factors affecting survival and risk in acute myeloid leukaemia
title_full_unstemmed TERT genetic variability and telomere length as factors affecting survival and risk in acute myeloid leukaemia
title_sort tert genetic variability and telomere length as factors affecting survival and risk in acute myeloid leukaemia
publisher Nature Portfolio
publishDate 2021
url https://doaj.org/article/11385e314e404688906129966ec49594
work_keys_str_mv AT martadratwa tertgeneticvariabilityandtelomerelengthasfactorsaffectingsurvivalandriskinacutemyeloidleukaemia
AT barbarawysoczanska tertgeneticvariabilityandtelomerelengthasfactorsaffectingsurvivalandriskinacutemyeloidleukaemia
AT aleksandrabutrym tertgeneticvariabilityandtelomerelengthasfactorsaffectingsurvivalandriskinacutemyeloidleukaemia
AT piotrłacina tertgeneticvariabilityandtelomerelengthasfactorsaffectingsurvivalandriskinacutemyeloidleukaemia
AT grzegorzmazur tertgeneticvariabilityandtelomerelengthasfactorsaffectingsurvivalandriskinacutemyeloidleukaemia
AT katarzynaboguniakubik tertgeneticvariabilityandtelomerelengthasfactorsaffectingsurvivalandriskinacutemyeloidleukaemia
_version_ 1718372117805793280